Back to search
FDAFDA · Food and drugs·Recall number D-010-2014

Spironolactone tablets, USP 25 mg, Rx only, 500 count bottle, Distributed By: Greenstone LLC, Peapack, NJ 07977, NDC: 59762-5011-2.

Published November 27, 2013 · Recall initiated: September 4, 2013

Summary

FDA records drug Class II recall D-010-2014, published November 27, 2013 and initiated September 4, 2013. Recalling firm: Greenstone Llc; Status: Terminated; Reported quantity: 2796 bottles; Lot: Lot #: V121207, V121208, Exp 03/31/2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed without an Approved NDA/ANDA: This recall is being initiated because of changes to the dissolution profile in distributed lots resulting from a manufacturing site change. There is currently no approved application supporting the alternate manufacturing site.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Greenstone Llc
Distributor
Nationwide and Puerto Rico
Lot
Lot #: V121207, V121208, Exp 03/31/2017
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Spironolactone tablets, USP 25 mg, Rx only, 500 count bottle, Distributed By: Greenstone LLC, Peapack, NJ 07977, NDC: 59762-5011-2. recalled?

Yes. FDA published recall D-010-2014 on November 27, 2013. Reported hazard: Marketed without an Approved NDA/ANDA: This recall is being initiated because of changes to the dissolution profile in distributed lots resulting from a manufacturing site change. There is currently no approved application supporting the alternate manufacturing site.

What should I do if I have this product?

Voluntary: Firm initiated · Letter